Overview

A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115)

Status:
Withdrawn
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if analgesic efficacy can be detected with single dose administration in patients with chronic neuropathic pain due to painful diabetic neuropathy.
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Diphenhydramine
Duloxetine Hydrochloride
Pregabalin
Promethazine